Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma

Survey of Ophthalmology

Volumn 43, Issue 6 SUPPL., 1999, Pages

  Haefliger, Ivan O ^a   Dettmann, Eike ^a   Liu, Rong ^a   Meyer, Peter ^a   Prünte, Christian ^a   Messerli, Jürg ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

Choroid; Endothelin; Endothelium derived relaxing factor; Endothelium derived contracting factor; Nitric oxide; Nitric oxide synthase; Normal tension glaucoma; Retina; Trabecular meshwork; Vasospasm

Indexed keywords

ENDOTHELIN; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; CARDIOVASCULAR AUTOREGULATION; CONFERENCE PAPER; ENZYME ACTIVITY; EYE BLOOD FLOW; GLAUCOMA; INTRAOCULAR PRESSURE; OPTIC NERVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RETINA GANGLION CELL; VASOCONSTRICTION; VASOSPASM;

APOPTOSIS; ARTERIES; BLOOD FLOW VELOCITY; CHRONIC DISEASE; ENDOTHELIN-1; EYE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; NITRIC OXIDE; RETINAL GANGLION CELLS; VASOCONSTRICTION;

EID: 0032776941     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(99)00026-0     Document Type: Conference Paper

References (81)

1. Allen J.B., Keng T., Privalle C. Nitric oxide and peroxynitrite production in ocular inflammation. Environ Health Perspect. 106(Suppl 5):1998;1145-1149.
2. Becquet F., Courtois Y., Goureau O., Nitric oxide in the eye multifaceted roles and diverse outcome. Surv Ophthalmol. 42:1997;71-82.
3. Behar-Cohen F.F., Goureau O., D'Hermies F., Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 37:1996;1711-1715.
4. Bdolah A., Wollberg Z., Fleminger G., Kochva E. SRTX-d, a new natural peptide of the endothelin/sarafotoxin family. FEBS Lett. 256:1989;1-3.
5. Bonfoco E., Krainc D., Ankarcrona M.et al. Apoptosis and necrosis. two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures Proc Natl Acad Sci U S A. 92:1995;7162-7166.
6. Bonne C., Muller A., Villain M. [The excito-toxicity theory of glaucomatous neuropathy. General review] J Fr Ophthalmol. 19:1996;69-74.
7. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
8. Brune B., von Knethen A., Sandau K.B. Nitric oxide and its role in apoptosis. Eur J Pharmacol. 35:1998;261-272.
9. Brune B., Sandau K., von Knethen A. Apoptotic cell death and nitric oxide. activating and antagonistic transducing pathways Biochemistry. 63:1998;817-825.
10. Cohen R.A. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 38:1995;105-128.
11. Darley-Usmar V., Halliwell B. Blood radicals. reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system Pharm Res. 13:1996;649-662.
12. Demiryurek A.T., Cakici I., Kanzik I. Peroxynitrite. a putative cytotoxin Pharmacol Toxicol. 82:1998;113-117.
13. Dreyer E.B., Pan Z.H., Storm S., Lipton S.A. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 5:1994;629-631.
14. Dreyer E.B., Zurakowski D., Schumer R.A.et al. Elevated levels in the vitreous body of human and monkeys with glaucoma. Arch Ophthalmol. 114:1996;299-305.
15. Ellis D., Nathanson J. Nitric oxide in the human eye. Sites of synthesis and physiological actions on intraocular pressure, blood flow, sodium transport and neuronal viability Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;178-204 Lippincott-Raven, New York.
16. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 38(Suppl):1994;S3-S6.
17. Flammer J, Hendrickson P (eds). Ocular Blood Flow: New Insights into the Pathogenesis of Ocular Diseases. Basel, Switzerland, Karger AG, 1996, pp 12-39.
18. Flammer J., Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Retin Eye Res. 17:1998;267-289.
19. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
20. Garcia-Valenzuela E., Shareef S., Walsh J.et al. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 61:1995;33-44.
21. Geller D.A., Billiar T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 17:1998;7-23.
22. Glovinsky Y., Quigley H.A., Dunkelberger G.R. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 32:1991;484-491.
23. Goldstein I.M., Ostwald P., Roth S. Nitric oxide. a review of its role in retinal function and disease Vision Res. 36:1996;2979-2994.
24. Greve E.L., Duijm H.F.A., Geijssen H.C. Risk factors in glaucoma. Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;1-13 Lippincott-Raven, New York.
25. Griffith O.W., Kilbourn R.G. Nitric oxide synthase inhibitors. amino acids Methods Enzymol. 268:1996;375-392.
26. Haefliger I.O., Anderson D.R. Oxygen modulation of guanylate cyclase-mediated retinal pericyte relaxations with 3-morpholino-sydnonimine and atrial natriuretic peptide. Invest Ophthalmol Vis Sci. 38:1997;1563-1568.
27. Haefliger I.O., Chen Q., Anderson D.R. Effect of oxygen on relaxation of retinal pericytes by sodium nitroprusside. Graefes Arch Clin Exp Ophthalmol. 235:1997;388-392.
28. Haefliger I.O., Dettmann E.S. Nitric oxide and endothelin in the pathogenesis of glaucoma. an overview Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;22-33 Lippincott-Raven, New York.
29. Haefliger I.O., Flammer J., Lüscher T.F. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 33:1992;2340-2343.
30. Haefliger I.O., Flammer J., Lüscher T.F. Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest Ophthalmol Vis Sci. 34:1993;1722-1730.
31. Haefliger I.O., Meyer P., Flammer J., Lüscher T.F. The vascular endothelium as a regulator of the ocular circulation. A new concept in ophthalmology Surv Ophthalmol. 39:1994;123-132.
32. Haefliger I.O., Zschauer A., Davis E.B., Anderson D.R. Relaxation of retinal pericytes contractile tone through the nitric oxide-cyclic GMP pathway. Invest Ophthalmol Vis Sci. 35:1994;991-997.
33. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 59:1992;1609-1623.
34. Kashii S., Mandai M., Kikuchi M.et al. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res. 71:1996;93-101.
35. Kerrigan L.A., Zack D.J., Quigley H.A.et al. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 115:1997;1031-1035.
36. + channels. Cell Calcium. 4:1983;421-428.
37. Lee C.Y., Chiappinelli V.A. Similarity of endothelin to snake venom toxin. Nature. 335:1988;303.
38. Lepple-Wienhues A., Stahl F., Willner U.et al. Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork. interaction with calcium, nifedipine and nickel Curr Eye Res. 10:1991;983-989.
39. Lopez-Farre A., Rodriguez-Feo J.A., Sanchez de Miguel L.et al. Role of nitric oxide in the control of apoptosis in the microvasculature. Int J Biochem Cell Biol. 30:1998;1095-1106.
40. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide. A physiologic messenger Ann Intern Med. 120:1994;227-237.
41. Lyons C.R., Orloff G.J., Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from murine macrophage cell line. J Biol Chem. 267:1992;6370-6374.
42. Mann R.M., Riva C.E., Stone R.A.et al. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 36:1995;925-930.
43. Mittal C.K., Harrell W.B., Mehta C.S. Interaction of heavy metal toxicants with brain constitutive nitric oxide synthase. Mol Cell Biochem. 149-150:1995;263-265.
44. Monard D. Mechanisms of neuronal apoptosis. Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;213-220 Lippincott-Raven, New York.
45. Moncada S., Higgs E.A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
46. Murphy M.P., Packer M.A., Scarlett J.L., Martin S.W. Peroxynitrite. a biologically significant oxidant Gen Pharmacol. 31:1998;179-186.
47. Nathanson J.A., McKee M. Alteration of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci. 36:1995;1774-1784.
48. Nathanson J.A., McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Opthalmol Vis Sci. 36:1995;1765-1773.
49. Nayler W.G. Other chemically-related toxins. Nayler G. The Endothelins. 1990;31-37 Springer-Verlag, Berlin.
50. Neufeld A.H., Hernandez M.R., Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol. 115:1997;497-503.
51. Nickells R.W. Retinal ganglion cell death in glaucoma. the how, the why, and the maybe J Glaucoma. 5:1996;345-356.
52. Nickells R.W., Zack D.J. Apoptosis in ocular disease. a molecular overview Ophthalmic Genet. 17:1996;145-165.
53. Noske W., Hensen J., Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of primary open angle glaucoma and cataract patients. Graefe's Arch Clin Exp Ophthalmol. 235:1997;551-552.
54. Okisaka S., Murakami A., Mizukawa A., Ito J. Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes. Jpn J Ophthalmol. 41:1997;84-88.
55. Pai N., Zdanski C.J., Gregory C.W.et al. Sodium nitroprusside/nitric oxide causes apoptosis in spiral ganglion cells. Otolaryngol Head Neck Surg. 119:1998;323-330.
56. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1998;664-666.
57. Petros A., Lamb G., Leone A.et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 28:1994;34-39.
58. Quigley H.A., Dunkelberger G.R., Green W.R. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 95:1988;357-363.
59. Quigley H.A., Nickells R.W., Kerrigan L.A.et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 36:1995;774-786.
60. Richter C. Nitric oxide and its congeners in mitochondria. implications for apoptosis Environ Health Perspect. 106(Suppl 5):1998;1125-1130.
61. Roth S. Role of nitric oxide in retinal cell death. Clin Neurosci. 4:1997;216-223.
62. Saran M., Bors W. Radical reactions in vivo - an overview. Radiat Environ Biophys. 29:1990;249-262.
63. Shields M.B. Optic nerve head and peripapillary retina, in Textbook of Glaucoma. 1998;Williams & Wilkins, Baltimore.
64. Shimokawa H., Tomoike H., Nabeyama S.et al. Coronary artery spasms induced in atherosclerotic miniature swine. Science. 221:1983;560-562.
65. Stamler J.S., Feelisch M. Biochemistry of nitric oxide and redox-related species. Feelisch M., Stamler J.S. Methods in Nitric Oxide Research. 1996;19-27 John Wiley & Sons, New York.
66. Tamm E.R., Lütjen-Drecoll E. Nitric oxide-synthesizing cells in the posterior eye segment. Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;68-78 Lippincott-Raven, New York.
67. Tamm E.R., Lütjen-Drecoll E. Nitric oxide in the outflow pathways of the aqueous humor. Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;158-167 Lippincott-Raven, New York.
68. Thiemermann C. The role of the L-arginine nitric oxide pathway in circulatory shock. Adv Pharmacol. 28:1994;45-79.
69. Tsia W.C., Strieter R.E., Zisman D.A.et al. Nitric oxide is required for effective innate immunity against Klebsbiella pneumoniae. Infect Immun. 65:1997;1870-1875.
70. Tunny T.J., Richardson K.A., Clark C.V. Association study of the 5' flanking regions of endothelial-nitric oxide synthase and endothelin-1 genes in familial primary open-angle glaucoma. Clin Exp Pharmacol Physiol. 25:1998;26-29.
71. Voet D., Voet J.G. Biochemical communications. hormones and neurotransmitters, in Biochemistry:1995;John Wiley & Sons, New York.
72. Vorwerk C.K., Hyman B.T., Miller J.W.et al. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest Ophthalmol Vis Sci. 38:1997;2038-2044.
73. Wenzel R.R., Lüscher T.F. Endothelin and endothelin antagonists. pharmacology and clinical implications Agents Actions Suppl. 45:1995;237-253.
74. Wiederholt M. Nitric oxide and endothelin in aqueous humor outflow regulation. Haefliger I.O., Flammer J. Nitric Oxide and Endothelin in the Pathogenesis of Glaucoma. 1998;168-177 Lippincott-Raven, New York.
75. Wiederholt M., Bielka S., Schweig F.et al. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp Eye Res. 6:1995;223-234.
76. Wiederholt M., Schafer R., Wagner U.et al. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger J Ophthalmol. 5:1996;146-153.
77. Wiederholt M., Sturm A., Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 35:1994;2515-2520.
78. Wink D.A., Beckman J.S., Ford P.C. Kinetics of nitric oxide reaction in liquid and gas phases. Felisch M., Stamler J.S. Methods in Nitric Oxide Research. 1996;27-37 John Wiley & Sons, New York.
79. Yamamoto T., Kitazawa Y. Vascular pathogenesis of normal-tension glaucoma. a possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropathy Prog Retin Eye Res. 17:1998;127-143.
80. Yanagisawa M., Kurihara H., Kimura S.et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
81. A-antagonist Invest Ophthalmol Vis Sci. 40:1999;1015-1020.